X-ZELL
PrivateLast Round
Grant
Nov 18, 2020
Est. Valuation
$1.71M
Total Funding Raised
$4.14M
Company Overview
X-ZELL operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Grant round in November 2020.
X-ZELL is a medical technology company that develops next-generation cytology platforms for the detection, visualization, and digitization of atypical cells in minimally invasive body liquids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
X-ZELL Comparables
Compare X-ZELL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RareCyte | 81% | |
| ScreenCell | 78% | |
| Menarini Group | 76% |
For institutional investors. Book with your work email.
X-ZELL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 18, 2020 | ||||
| Seed | Oct 15, 2020 | ||||
| Accelerator | Mar 23, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
X-ZELL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup SG | Grant |
| Essex Bio-Technology | Seed |
| MedTech Innovator | Grant |
| Deutsche Industrieanlagen | Seed |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Commercial launch of Cryophore multiplex antibody panels on March 1, 2026.
- Nov 18, 2020
$22K grant received from MedTech Innovator and Startup SG.
For institutional investors. Book with your work email.
X-ZELL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about X-ZELL's valuation, stock price, and market status.
Is X-ZELL a public or private company?
X-ZELL is a private company.
What is the current stock price of X-ZELL?
X-ZELL is a private company, so its shares have no public market price. Caplight tracks X-ZELL's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is X-ZELL worth (valuation)?
X-ZELL's valuation is estimated at $1.7M based on funding round data.
Can I buy X-ZELL stock?
X-ZELL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was X-ZELL's last funding round?
X-ZELL's most recent funding round was Grant on November 18, 2020.
Who are the main investors in X-ZELL?
Key investors in X-ZELL include Deutsche Industrieanlagen.
Will X-ZELL IPO soon?
No public IPO plans have been announced for X-ZELL.
How can I track X-ZELL secondary market activity?
Caplight tracks bids, offers, and trades in X-ZELL's shares on secondary markets.